Human Gb3/CD77 synthase produces P1 glycotope-capped N-glycans, which mediate Shiga toxin 1 but not Shiga toxin 2 cell entry

• Published in: The Journal of biological chemistry 2021-01, Vol.296, p.100299-100299, Article 100299
• Main Authors: Szymczak-Kulus, Katarzyna, Weidler, Sascha, Bereznicka, Anna, Mikolajczyk, Krzysztof, Kaczmarek, Radoslaw, Bednarz, Bartosz, Zhang, Tao, Urbaniak, Anna, Olczak, Mariusz, Park, Enoch Y., Majorczyk, Edyta, Kapczynska, Katarzyna, Lukasiewicz, Jolanta, Wuhrer, Manfred, Unverzagt, Carlo, Czerwinski, Marcin
• Format: Article
• Language: English
• Subjects: A4GALT; Acetylgalactosamine - chemistry; Acetylgalactosamine - metabolism; Acetylglucosamine - chemistry; Acetylglucosamine - metabolism; Animals; Binding Sites; Carbohydrate Sequence; CHO Cells; Cricetulus; Enterohemorrhagic Escherichia coli - chemistry; Enterohemorrhagic Escherichia coli - pathogenicity; Galactose - chemistry; Galactose - metabolism; Galactosyltransferases - chemistry; Galactosyltransferases - genetics; Galactosyltransferases - metabolism; Gene Expression; Globosides - biosynthesis; Globosides - chemistry; Globosides - metabolism; globotriaosylceramide (Gb3); Glucose - chemistry; Glucose - metabolism; glycolipid; glycoprotein; glycosylation inhibitor; glycosyltransferase; Humans; Models, Molecular; Mutation; N-glycan; P1 antigen; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; receptor; Recombinant Proteins - chemistry; Recombinant Proteins - genetics; Recombinant Proteins - metabolism; Shiga toxin; Shiga Toxin 1 - chemistry; Shiga Toxin 1 - metabolism; Shiga Toxin 2 - chemistry; Shiga Toxin 2 - metabolism; Trihexosylceramides - biosynthesis; Trihexosylceramides - chemistry
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1016/j.jbc.2021.100299

The human Gb3/CD77 synthase, encoded by the A4GALT gene, is an unusually promiscuous glycosyltransferase. It synthesizes the Galα1→4Gal linkage on two different glycosphingolipids (GSLs), producing globotriaosylceramide (Gb3, CD77, Pk) and the P1 antigen. Gb3 is the major receptor for Shiga toxins (Stxs) produced by enterohemorrhagic Escherichia coli. A single amino acid substitution (p.Q211E) ramps up the enzyme’s promiscuity, rendering it able to attach Gal both to another Gal residue and to GalNAc, giving rise to NOR1 and NOR2 GSLs. Human Gb3/CD77 synthase was long believed to transfer Gal only to GSL acceptors, therefore its GSL products were, by default, considered the only human Stx receptors. Here, using soluble, recombinant human Gb3/CD77 synthase and p.Q211E mutein, we demonstrate that both enzymes can synthesize the P1 glycotope (terminal Galα1→4Galβ1→4GlcNAc-R) on a complex type N-glycan and a synthetic N-glycoprotein (saposin D). Moreover, by transfection of CHO-Lec2 cells with vectors encoding human Gb3/CD77 synthase and its p.Q211E mutein, we demonstrate that both enzymes produce P1 glycotopes on N-glycoproteins, with the mutein exhibiting elevated activity. These P1-terminated N-glycoproteins are recognized by Stx1 but not Stx2 B subunits. Finally, cytotoxicity assays show that Stx1 can use P1 N-glycoproteins produced in CHO-Lec2 cells as functional receptors. We conclude that Stx1 can recognize and use P1 N-glycoproteins in addition to its canonical GSL receptors to enter and kill the cells, while Stx2 can use GSLs only. Collectively, these results may have important implications for our understanding of the Shiga toxin pathology.